Edition:
United States

MiMedx Group Inc (MDXG.OQ)

MDXG.OQ on NASDAQ Stock Exchange Capital Market

13.94USD
16 Jan 2018
Change (% chg)

-- (--)
Prev Close
$13.94
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
724,417
52-wk High
$17.47
52-wk Low
$7.64

Select another date:

Tue, Jan 16 2018

BRIEF-Mimedx Announces First Patients Have Been Enrolled In The Phase 3 Clinical Trial Of Amniofix

* MIMEDX ANNOUNCES FIRST PATIENTS HAVE BEEN ENROLLED IN THE PHASE 3 CLINICAL TRIAL OF AMNIOFIX® INJECTABLE IN PATIENTS WITH RECALCITRANT PLANTAR FASCIITIS PAIN

BRIEF-Mimedx Settles Patent Infringement Lawsuit

* MIMEDX - SUCCESSFULLY SETTLED CO'S PATENT INFRINGEMENT LAWSUIT AGAINST MUSCULOSKELETAL TRANSPLANT FOUNDATION, MEDLINE INDUSTRIES, LIVENTA BIOSCIENCE

BRIEF-MiMedx Agrees To Lawsuit Settlement With Former Employee

* MIMEDX GROUP INC - COMPANY HAS AGREED TO A CONFIDENTIAL LAWSUIT SETTLEMENT FROM ONE FORMER EMPLOYEE

BRIEF-MiMedx Forecasts 2018 Revenue To Be In Range Of $383 Mln To $387 Mln

* MIMEDX FORECASTS 2018 REVENUE TO BE IN THE RANGE OF $383 MILLION TO $387 MILLION

BRIEF-MiMedx Says It Expects To Exceed Top End Of Q4 Revenue Guidance Of $88 Mln

* MIMEDX ANNOUNCES EXPECTATION TO EXCEED TOP END OF FOURTH QUARTER REVENUE GUIDANCE OF $88 MILLION

BRIEF-Mimedx provides update on its reimbursement coverage

* Mimedx Group Inc - ‍provided a reimbursement update in light of FDA final and draft guidance documents related to human tissue​

BRIEF-MiMedx Group sees FY 2017 revenue $320.6 million to $321.6 million

* MiMedx Group Inc - ‍reiterates Q4 and full year 2017 guidance​

BRIEF-MiMedx announces Q3 2017 results

* MiMedx announces record results for third quarter of 2017 and raises full year revenue guidance

BRIEF-Mimedx Group Inc preliminary Q3 revenue $84.6 million

* Announces third quarter revenues of $84.6 million exceeds guidance by more than 5 percent

BRIEF-MiMedx board authorizes $10 mln increase to share repurchase program

* MiMedx board of directors authorizes $10 million increase to the company's share repurchase program

Select another date: